Antiviral drugs are a specific class of drugs used in the treatment of infections caused by viruses. Most of the antiviral drugs are used in the treatment of infections caused by a specific virus; however, broad spectrum antiviral drugs are effective against a wide range of viral infections. Most of the antimicrobial drugs such as antivirals and antibiotics only prevent the growth or development of microorganism and not destroy the target. Most of the antiviral drugs are considered comparatively harmless to the host and can be used to treat infections. These antiviral drugs are different from viricides. Viricides are not medicines; however, these are able to destroy or neutralize the virus particles in both the inside and outside of the body. There are also some natural antiviral drugs available derived from plants such as eucalyptus.
Antiviral boosters are drugs used in combination with other specific antiviral drugs to increase or enhance the effect. For instance, Norvir and Tybost are antiviral booster drugs. Norvir is an antiviral drug used in the prevention of HIV (human immunodeficiency virus) virus infection to multiply and increase its number in the body. Norvir is used in combination with other antiviral drugs as antiviral booster to treat HIV, the virus that can cause AIDS (against acquired immunodeficiency syndrome). Tybost is another antiviral booster drug used in combination with other antiviral drugs. It contains an active ingredient cobicistat, which reduces the enzymatic activity in the liver which breaks specific antiviral drug. Tybost makes antiviral drugs more effective and safe in lower dose. It is given in combination with prezista (Darunavir) or reyataz (Atazanavir) for the treatment of HIV. Tybost itself is not an antiviral agent. It is used only as antiviral boosting agent against viral infection.
Increase in incidence rate of viral infectious diseases such as respiratory syncytial virus, influenza, human immunodeficiency virus, and epidemic viral infection across the globe drive the global antiviral booster drugs market. Novel and advanced antiviral drug formulations, strong R&D, and increased R&D expense by the global players also propel the market. However, high cost of R&D and significant risk of failure are the major factors that restrain the market.
The global antiviral booster drugs market can be segmented based on application, end-user, distribution channel, and region. In terms of application, the global market can be classified into HIV antivirals, influenza, herpes virus, hepatitis-B antivirals, hepatitis-C antivirals, and others. Based on end user, the global antiviral booster drugs market can be categorized into ambulatory surgical centers, clinics, and hospitals. In terms of distribution channel, the global market can be divided into hospital pharmacies, online pharmacies, and retail pharmacies.
The global antiviral booster drugs market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global antiviral booster drugs market due to availability of advanced medications. Awareness among the people about diseases is also a major factor boosting the market in the region. The antiviral booster drugs market in Asia Pacific is anticipated to grow at a rapid pace due to increase in prevalence of HIV. Lack of awareness about the disease and unavailability of advanced medication and treatment in underdeveloped countries such as Lebanon, Syria, Cyprus, Turkey, and Iraq is likely to propel the antiviral booster drugs market in Middle East & Africa.
Key players in the global antiviral booster drugs market include AbbVie, Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, and Abbott.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.